“NQF’s recent endorsement of 11 quality measures of patient safety includes three measures developed by the Pharmacy Quality Alliance (PQA) to address the use of opioids at high dosage or from multiple providers, with appropriate exclusions, including cancer patients. These are the first NQF-endorsed measures intended to address the nation’s devastating—and growing—opioid epidemic. Each was thoughtfully considered and, ultimately, recommended for endorsement by NQF’s Patient Safety Standing Committee…”
NQF Statement on Endorsement of Opioid Patient Safety Measures
More from United StatesMore posts in United States »
- New AHRQ MEPS Statistical Brief Finds Number of Americans Receiving Treatment for Osteoarthritis Decreased Significantly from 2016-2020
- Study Finds Underreporting of Quality Measures Leading to Data Inaccuracies on Nursing Home Care Compare Website
- Study Finds Black Patients had Longer Admissions for Sepsis, Respiratory Failure, Compared with White Patients
- The Leapfrog Group Releases 2023 Maternity Care Report
- New Prescription Drug Pricing transparency report released by Virginia Health Information